NO20012825D0 - Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering - Google Patents
Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhaleringInfo
- Publication number
- NO20012825D0 NO20012825D0 NO20012825A NO20012825A NO20012825D0 NO 20012825 D0 NO20012825 D0 NO 20012825D0 NO 20012825 A NO20012825 A NO 20012825A NO 20012825 A NO20012825 A NO 20012825A NO 20012825 D0 NO20012825 D0 NO 20012825D0
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- particles
- inhalation
- powders
- preparation
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 5
- 239000002245 particle Substances 0.000 title abstract 4
- 239000000843 powder Substances 0.000 title abstract 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 239000011149 active material Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Glanulating (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Carbon And Carbon Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9827145.5A GB9827145D0 (en) | 1998-12-09 | 1998-12-09 | Improvements in or relating to powders |
| PCT/GB1999/004156 WO2000033811A2 (en) | 1998-12-09 | 1999-12-09 | Improvements in or relating to powders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012825D0 true NO20012825D0 (no) | 2001-06-08 |
| NO20012825L NO20012825L (no) | 2001-06-08 |
Family
ID=10843948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012825A NO20012825L (no) | 1998-12-09 | 2001-06-08 | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6989155B1 (no) |
| EP (1) | EP1137399B1 (no) |
| JP (1) | JP4410942B2 (no) |
| KR (1) | KR20010101138A (no) |
| CN (1) | CN1334723A (no) |
| AT (1) | ATE240093T1 (no) |
| AU (1) | AU770461B2 (no) |
| BR (1) | BR9916102A (no) |
| CA (1) | CA2353448C (no) |
| CZ (1) | CZ20012043A3 (no) |
| DE (1) | DE69907951T2 (no) |
| DK (1) | DK1137399T3 (no) |
| EA (1) | EA004045B1 (no) |
| ES (1) | ES2198973T3 (no) |
| GB (1) | GB9827145D0 (no) |
| HU (1) | HUP0104513A3 (no) |
| MX (1) | MXPA01005584A (no) |
| NO (1) | NO20012825L (no) |
| NZ (1) | NZ511965A (no) |
| PL (1) | PL348831A1 (no) |
| PT (1) | PT1137399E (no) |
| SK (1) | SK284775B6 (no) |
| TR (1) | TR200101591T2 (no) |
| WO (1) | WO2000033811A2 (no) |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US9006175B2 (en) * | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| EP2280020B1 (en) | 1999-06-29 | 2016-02-17 | MannKind Corporation | Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
| US6586008B1 (en) * | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| JP2001151673A (ja) * | 1999-09-06 | 2001-06-05 | Nikken Chem Co Ltd | 吸入用粉末製剤の製造方法 |
| EP1296651B2 (en) | 2000-06-27 | 2019-07-17 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| DK1296651T3 (da) * | 2000-06-27 | 2008-02-11 | Vectura Ltd | Fremgangsmåde til fremstilling af partikler til anvendelse i et farmaceutisk præparat |
| EP1337241B1 (en) † | 2000-11-30 | 2008-01-02 | Vectura Limited | Method of preparing microparticles for use in pharmaceutical compositions for inhalation |
| EP2168571B1 (en) * | 2000-11-30 | 2018-08-22 | Vectura Limited | Particles for use in a Pharmaceutical Composition |
| US8048451B2 (en) * | 2000-11-30 | 2011-11-01 | Vectura Limited | Pharmaceutical compositions for inhalation |
| WO2003043585A2 (en) | 2001-11-20 | 2003-05-30 | Advanced Inhalation Research, Inc. | Improved particulate compositions for pulmonary delivery |
| US20110123574A1 (en) * | 2002-03-20 | 2011-05-26 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| US7754242B2 (en) | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| ES2300568T3 (es) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
| CA2478327A1 (en) * | 2002-03-20 | 2003-10-02 | Advanced Inhalation Research, Inc. | Hgh (human growth hormone) formulations for pulmonary administration |
| ES2718455T3 (es) * | 2002-03-20 | 2019-07-02 | Civitas Therapeutics Inc | Formulaciones terapéuticas sostenidas inhalables |
| JP2006522785A (ja) * | 2003-04-14 | 2006-10-05 | ベクトゥラ・リミテッド | アポモルヒネを含む肺吸入用医薬組成物 |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| BRPI0514263B8 (pt) | 2004-08-20 | 2021-05-25 | Mannkind Corp | método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida |
| KR101306384B1 (ko) | 2004-08-23 | 2013-09-09 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는디케토디옥산염 |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| CA2597557A1 (en) | 2005-02-10 | 2006-08-17 | Glaxo Group Limited | Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom |
| WO2007019229A1 (en) * | 2005-08-05 | 2007-02-15 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
| MX381952B (es) | 2005-09-14 | 2025-03-13 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| JP5599975B2 (ja) | 2006-02-22 | 2014-10-01 | マンカインド コーポレイション | ジケトピペラジン及び活性薬剤を含有する微粒子の製剤特性の改善方法 |
| DE102006030164A1 (de) * | 2006-06-29 | 2008-01-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Pulver |
| DE102006053375A1 (de) | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
| US20090048155A1 (en) | 2007-08-15 | 2009-02-19 | Endacea, Inc. | Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| WO2011163272A1 (en) | 2010-06-21 | 2011-12-29 | Mannkind Corporation | Dry powder drug delivery system and methods |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| US9522916B2 (en) | 2007-12-21 | 2016-12-20 | Constance Neely Wilson | A1 adenosine receptor antagonists |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| KR101762089B1 (ko) | 2008-06-13 | 2017-07-26 | 맨카인드 코포레이션 | 건조 분말 흡입기 및 약물 투여 시스템 |
| ES2421385T3 (es) | 2008-06-20 | 2013-09-02 | Mannkind Corp | Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación |
| TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| LT3578169T (lt) | 2009-02-26 | 2024-08-26 | Glaxo Group Limited | Farmaciniai preparatai, apimantys 4-{(1r)-2-[(6-{2-[(2,6-dichlorbenzil) oksi]etoksi}heksil)amino]-1-hidroksietil}-2-(hidroksimetil)fenolį |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| MX2011013312A (es) | 2009-06-12 | 2012-01-25 | Mankind Corp | Microparticulas de dicetopiperazina con areas de superficie especificas definidas. |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| US9877967B2 (en) | 2010-01-26 | 2018-01-30 | Endacea, Inc. | Methods and pharmaceutical compositions for preventing and treating renal impairment |
| EP2464346A1 (en) * | 2010-08-30 | 2012-06-20 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| EP2621484A1 (en) | 2010-09-29 | 2013-08-07 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
| AU2015249177B2 (en) * | 2010-11-09 | 2017-08-03 | Mannkind Corporation | Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines |
| MX376862B (es) * | 2010-11-09 | 2025-03-07 | Mannkind Corp | Composicion que comprende un agonista de receptor de serotonina y una dicetopiperazina para el tratamiento de migrañas. |
| ES2625858T3 (es) | 2011-04-01 | 2017-07-20 | Mannkind Corporation | Paquete de tipo blíster para cartuchos farmacéuticos |
| RU2448717C1 (ru) * | 2011-04-20 | 2012-04-27 | Закрытое акционерное общество Научно-производственное предприятие "Тринита" | Способ получения антикоагулянтно-фибринолитического средства на основе гепарина |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| ES2708218T3 (es) | 2011-08-01 | 2019-04-09 | Univ Monash | Método y formulación para inhalación |
| CN103945859A (zh) | 2011-10-24 | 2014-07-23 | 曼金德公司 | 用于治疗疼痛的方法和组合物 |
| CN108057154B (zh) | 2012-07-12 | 2021-04-16 | 曼金德公司 | 干粉药物输送系统和方法 |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| WO2014106727A1 (en) | 2013-01-03 | 2014-07-10 | Vectura Limited | Inhaler and formulation |
| WO2014144895A1 (en) | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| CN105324106A (zh) | 2013-04-01 | 2016-02-10 | 普马特里克斯营业公司 | 噻托铵干粉 |
| EP3021834A1 (en) | 2013-07-18 | 2016-05-25 | MannKind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
| WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| DK3212212T3 (da) | 2014-10-31 | 2020-12-21 | Univ Monash | Pulverformulering |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| ES2908479T3 (es) | 2015-08-26 | 2022-04-29 | Achillion Pharmaceuticals Inc | Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios |
| EP3455219A4 (en) | 2016-05-10 | 2019-12-18 | C4 Therapeutics, Inc. | AMINE-RELATED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION |
| SG11201811491YA (en) | 2016-06-27 | 2019-01-30 | Achillion Pharmaceuticals Inc | Quinazoline and indole compounds to treat medical disorders |
| CN110603252A (zh) | 2017-03-01 | 2019-12-20 | 艾其林医药公司 | 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物 |
| EP3592352A1 (en) * | 2017-03-07 | 2020-01-15 | Philip Morris Products S.a.s. | Inhalable nicotine formulations, and methods of making and using thereof |
| WO2019118370A1 (en) * | 2017-12-12 | 2019-06-20 | Xotramorphic, Llc | Compositions, methods, and systems for producing flocculent materials for special effects |
| CN111902141A (zh) | 2018-03-26 | 2020-11-06 | C4医药公司 | 用于ikaros降解的羟脑苷脂结合剂 |
| CN110441198A (zh) * | 2018-05-03 | 2019-11-12 | 人福普克药业（武汉）有限公司 | 一种检测尼达尼布软胶囊中尼达尼布粒径的方法 |
| JP7538113B2 (ja) | 2018-08-20 | 2024-08-21 | アキリオン ファーマシューティカルズ，インコーポレーテッド | 補体ｄ因子の医学的障害の治療のための医薬化合物 |
| EP3866773B1 (en) | 2018-10-16 | 2024-08-28 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| JP2023515073A (ja) | 2020-02-20 | 2023-04-12 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 補体因子ｄ媒介障害の処置用のヘテロアリール化合物 |
| CN115279370B (zh) | 2020-03-05 | 2025-01-10 | C4医药公司 | 用于brd9的靶向降解的化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| US6136346A (en) | 1995-04-14 | 2000-10-24 | Inhale Therapeutic Systems | Powdered pharmaceutical formulations having improved dispersibility |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| WO2001032144A1 (en) * | 1999-10-29 | 2001-05-10 | Inhale Therapeutic Systems, Inc. | Dry powder compositions having improved dispersivity |
-
1998
- 1998-12-09 GB GBGB9827145.5A patent/GB9827145D0/en not_active Ceased
-
1999
- 1999-12-09 HU HU0104513A patent/HUP0104513A3/hu unknown
- 1999-12-09 CZ CZ20012043A patent/CZ20012043A3/cs unknown
- 1999-12-09 US US09/857,392 patent/US6989155B1/en not_active Expired - Fee Related
- 1999-12-09 TR TR2001/01591T patent/TR200101591T2/xx unknown
- 1999-12-09 SK SK777-2001A patent/SK284775B6/sk unknown
- 1999-12-09 DE DE69907951T patent/DE69907951T2/de not_active Expired - Lifetime
- 1999-12-09 AU AU15777/00A patent/AU770461B2/en not_active Ceased
- 1999-12-09 AT AT99958404T patent/ATE240093T1/de not_active IP Right Cessation
- 1999-12-09 PT PT99958404T patent/PT1137399E/pt unknown
- 1999-12-09 PL PL99348831A patent/PL348831A1/xx not_active IP Right Cessation
- 1999-12-09 DK DK99958404T patent/DK1137399T3/da active
- 1999-12-09 CN CN99816052A patent/CN1334723A/zh active Pending
- 1999-12-09 WO PCT/GB1999/004156 patent/WO2000033811A2/en active IP Right Grant
- 1999-12-09 NZ NZ511965A patent/NZ511965A/en not_active IP Right Cessation
- 1999-12-09 ES ES99958404T patent/ES2198973T3/es not_active Expired - Lifetime
- 1999-12-09 MX MXPA01005584A patent/MXPA01005584A/es unknown
- 1999-12-09 JP JP2000586305A patent/JP4410942B2/ja not_active Expired - Fee Related
- 1999-12-09 KR KR1020017007067A patent/KR20010101138A/ko not_active Application Discontinuation
- 1999-12-09 EA EA200100636A patent/EA004045B1/ru not_active IP Right Cessation
- 1999-12-09 CA CA2353448A patent/CA2353448C/en not_active Expired - Fee Related
- 1999-12-09 BR BR9916102-8A patent/BR9916102A/pt not_active Application Discontinuation
- 1999-12-09 EP EP99958404A patent/EP1137399B1/en not_active Expired - Lifetime
-
2001
- 2001-06-08 NO NO20012825A patent/NO20012825L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1334723A (zh) | 2002-02-06 |
| EP1137399A2 (en) | 2001-10-04 |
| ATE240093T1 (de) | 2003-05-15 |
| HUP0104513A2 (hu) | 2002-03-28 |
| AU1577700A (en) | 2000-06-26 |
| EA004045B1 (ru) | 2003-12-25 |
| DE69907951D1 (de) | 2003-06-18 |
| WO2000033811A3 (en) | 2000-10-12 |
| NZ511965A (en) | 2003-09-26 |
| US6989155B1 (en) | 2006-01-24 |
| BR9916102A (pt) | 2001-09-04 |
| CA2353448C (en) | 2010-02-23 |
| MXPA01005584A (es) | 2003-07-14 |
| CZ20012043A3 (cs) | 2001-12-12 |
| WO2000033811A2 (en) | 2000-06-15 |
| EA200100636A1 (ru) | 2001-12-24 |
| GB9827145D0 (en) | 1999-02-03 |
| NO20012825L (no) | 2001-06-08 |
| DE69907951T2 (de) | 2004-03-11 |
| SK284775B6 (sk) | 2005-11-03 |
| SK7772001A3 (en) | 2001-12-03 |
| KR20010101138A (ko) | 2001-11-14 |
| DK1137399T3 (da) | 2003-08-18 |
| CA2353448A1 (en) | 2000-06-15 |
| PL348831A1 (en) | 2002-06-17 |
| JP4410942B2 (ja) | 2010-02-10 |
| ES2198973T3 (es) | 2004-02-01 |
| HUP0104513A3 (en) | 2003-12-29 |
| PT1137399E (pt) | 2003-09-30 |
| JP2002531487A (ja) | 2002-09-24 |
| TR200101591T2 (tr) | 2001-11-21 |
| EP1137399B1 (en) | 2003-05-14 |
| AU770461B2 (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012825D0 (no) | Aminosyrepartikler, fremgangsmåte for fremstilling og anvendelse av slike i pulvere for innhalering | |
| GB9807232D0 (en) | Aerosol composition | |
| CA2432175A1 (en) | Storage stable powder compositions of interleukin-4 receptor | |
| AU2003258706A1 (en) | Powder inhaler | |
| DK1283036T3 (da) | Törpulver til inhalation | |
| MY132999A (en) | New formulation for inhalation | |
| CY1110136T1 (el) | Συνθεσεις ξηρης σκονης με βελτιωμενη διασπαρσιμοτητα | |
| CA2183577A1 (en) | Methods and compositions for pulmonary delivery of insulin | |
| CA2211874A1 (en) | Carrier particles for use in dry powder inhalers | |
| WO2005025535A8 (en) | Methods for preparing pharmaceutical compositions | |
| TR200101442T2 (tr) | HFA 227 ve HFA 137 ihtiva eden farmasötik aeorosol bileşimi | |
| PL343342A1 (en) | Particulate active agent support for pulmonary application | |
| CA2277914A1 (en) | New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide | |
| MXPA03000321A (es) | Formulaciones de macrolido para inhalacion y metodos de tratamiento de infecciones endobronquiales. | |
| PL355688A1 (en) | Antistatic powder coating compositions and their use | |
| AU1701402A (en) | Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses | |
| AR007807A1 (es) | Polvo de aspartame para la aplicacion en mezclas de polvos y procedimiento para su preparacion | |
| MX2022015578A (es) | Composiciones en polvo de anatabina. | |
| HUP9902788A1 (hu) | Porlasztható makromolekuláris gyógyszerkészítmények, valamint előállításuk és alkalmazásuk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |